CXCR3 antagonists can block the binding of CXCR3 to its ligands, thereby inhibiting the biological signaling axis, which may offer therapeutic benefits for conditions such as tumors and autoimmune diseases. The gene discussed is CXCR3; the disease is autoimmune disease.